We are live on ! Find out more
AUXL

AUXILIUM PHARAMCEUTICALS INC
AUXL

Delisted

AUXL was delisted on the 29th of January, 2015.

Back to rankings

147 hedge funds and large institutions have $1.11B invested in AUXILIUM PHARAMCEUTICALS INC in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 61 increasing their positions, 49 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,948% more call options, than puts

Call options by funds: $191M | Put options by funds: $9.33M

24% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 49

12% more capital invested

Capital invested by funds: $987M → $1.11B (+$120M)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

2% less funds holding

Funds holding: 150 → 147 (-3)

12% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 25

Holders
147
Holders Change
-3
Holders Change %
-2%
% of All Funds
4.27%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.17%
New
22
Increased
61
Reduced
49
Closed
25
Calls
$191M
Puts
$9.33M
Net Calls
+$182M
Net Calls Change
+$49.4M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$30.6M
2
TCP
TAMRO Capital Partners
Virginia
+$17.9M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.7M
4
TCM
Tamarack Capital Management
California
+$13.7M
5
PHS
PFM Health Sciences
California
+$11.9M

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$21.4M
2
Citadel Advisors
Citadel Advisors
Florida
-$20.6M
3
SCA
SAC Capital Advisors
Connecticut
-$13.4M
4
Invesco
Invesco
Georgia
-$11M
5
MHP
Manatuck Hill Partners
Connecticut
-$10.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
STMM
26
South Texas Money Management
Texas
$9.04M +$2.46M +130,577 +43%
SCA
27
SAC Capital Advisors
Connecticut
$8.79M -$13.4M -713,050 -63%
Norges Bank
28
Norges Bank
Norway
$8.04M – – –
TA
29
Teachers Advisors
New York
$7.68M +$53.5K +2,840 +0.8%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$7.09M +$1.23M +65,447 +24%
HVC
31
Healthcare Value Capital
New Jersey
$6.93M +$943K +50,000 +18%
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$6.76M +$5.84M +309,833 +1,921%
KIA
33
King Investment Advisors
Texas
$6.49M -$2.49M -132,095 -30%
JP Morgan Chase
34
JP Morgan Chase
New York
$5.67M +$41.6K +2,208 +0.8%
Bank of America
35
Bank of America
North Carolina
$5.61M -$1.95M -103,542 -28%
Deutsche Bank
36
Deutsche Bank
Germany
$5.33M -$1.22M -64,681 -20%
Goldman Sachs
37
Goldman Sachs
New York
$5.09M +$548K +29,089 +13%
Geode Capital Management
38
Geode Capital Management
Massachusetts
$4.69M +$82.7K +4,385 +2%
CS
39
Credit Suisse
Switzerland
$4.51M +$1.91M +101,207 +87%
Barclays
40
Barclays
United Kingdom
$4.44M +$2.23M +118,226 +114%
AllianceBernstein
41
AllianceBernstein
Tennessee
$4.4M +$303K +16,060 +8%
Wells Fargo
42
Wells Fargo
California
$4.39M +$525K +27,843 +15%
TCIM
43
TIAA CREF Investment Management
New York
$4.37M -$997K -52,876 -20%
Axa
44
Axa
France
$4.05M +$183K +9,708 +5%
PAMU
45
Pictet Asset Management (UK)
United Kingdom
$3.73M -$1.43M -75,700 -30%
TCM
46
Tekla Capital Management
Massachusetts
$3.59M -$1.45M -77,000 -31%
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$3.34M +$9.31K +494 +0.3%
Millennium Management
48
Millennium Management
New York
$3.23M -$2.72M -144,294 -48%
Allianz Asset Management
49
Allianz Asset Management
Germany
$2.94M -$977K -51,800 -27%
Macquarie Group
50
Macquarie Group
Australia
$2.87M +$749K +39,724 +40%
1
2
3 4 5

AUXL Hedge Fund Activity: Q4 2013 in Review

147 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in AUXILIUM PHARAMCEUTICALS INC (AUXL) for Q4 2013, worth a combined $1.11B — up 12% from $987M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of AUXL and 22 opened new positions — a net loss of 3 holders — while 49 trimmed existing stakes and 61 added.

The largest buyer was Deerfield Management, adding an estimated $30.6M. The largest seller was Artal Group, cutting an estimated $21.4M.

  • 147 institutional investors held AUXILIUM PHARAMCEUTICALS INC (AUXL) as of Q4 2013, down from 150 in Q3 2013.
  • Funds reported $1.11B of AUXILIUM PHARAMCEUTICALS INC stock for Q4 2013, up 12% quarter-over-quarter.
  • 22 funds opened new AUXILIUM PHARAMCEUTICALS INC positions in Q4 2013 and 25 closed out, a net change of -3 holders.
  • The largest AUXILIUM PHARAMCEUTICALS INC buyer in Q4 2013 was Deerfield Management, an estimated $30.6M added.
  • The largest AUXILIUM PHARAMCEUTICALS INC seller in Q4 2013 was Artal Group, an estimated $21.4M sold.

Based on aggregated 13F filings for Q4 2013.